+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

Non-Insulin Therapies for Diabetes Market Report 2026 - Product Thumbnail Image

Non-Insulin Therapies for Diabetes Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Basal Insulin - Global Strategic Business Report - Product Thumbnail Image

Basal Insulin - Global Strategic Business Report

  • Report
  • June 2026
  • 179 Pages
  • Global
From
From
Prediabetes Market - Global Strategic Business Report - Product Thumbnail Image

Prediabetes Market - Global Strategic Business Report

  • Report
  • June 2026
  • 287 Pages
  • Global
From
From
From
Diabetes Drugs - Global Strategic Business Report - Product Thumbnail Image

Diabetes Drugs - Global Strategic Business Report

  • Report
  • June 2026
  • 478 Pages
  • Global
From
From
From
From
From
From
Insulin Pen Needles - Global Strategic Business Report - Product Thumbnail Image

Insulin Pen Needles - Global Strategic Business Report

  • Report
  • June 2026
  • 193 Pages
  • Global
From
From
From
From
Non-Insulin Diabetes Therapeutics Market 2026-2030 - Product Thumbnail Image

Non-Insulin Diabetes Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 286 Pages
  • Global
From
Insulin Market 2026-2030 - Product Thumbnail Image

Insulin Market 2026-2030

  • Report
  • January 2026
  • 281 Pages
  • Global
From
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more